Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nabriva Therapeutics Plc (NBRV) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nabriva Therapeutics Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1641640.
Total stock buying since 2017: $1,215,882.
Total stock sales since 2017: $3,249,785.
Total stock option exercises since 2017: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 51,839 | $9,581 | 0 | $0 |
| 2021 | 157,000 | $117,928 | 3,987 | $4,783 | 0 | $0 |
| 2020 | 0 | $0 | 11,064 | $7,169 | 94,750 | $0 |
| 2019 | 64,977 | $119,951 | 0 | $0 | 94,750 | $0 |
| 2018 | 156,160 | $432,216 | 0 | $0 | 0 | $0 |
| 2017 | 58,788 | $545,787 | 296,934 | $3,228,252 | 2,585 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-08 | 0 | $0 | 51,839 | $9,581 | 0 | $0 |
| 2021-12 | 107,000 | $61,429 | 0 | $0 | 0 | $0 |
| 2021-09 | 50,000 | $56,499 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 3,987 | $4,783 | 0 | $0 |
| 2020-08 | 0 | $0 | 11,064 | $7,169 | 94,750 | $0 |
| 2019-08 | 64,977 | $119,951 | 0 | $0 | 94,750 | $0 |
| 2018-12 | 53,000 | $69,430 | 0 | $0 | 0 | $0 |
| 2018-07 | 50,500 | $138,875 | 0 | $0 | 0 | $0 |
| 2018-06 | 20,500 | $77,315 | 0 | $0 | 0 | $0 |
| 2018-05 | 32,160 | $146,596 | 0 | $0 | 0 | $0 |
| 2017-11 | 1,569 | $9,869 | 0 | $0 | 0 | $0 |
| 2017-09 | 57,219 | $535,918 | 36,608 | $313,402 | 1,350 | $0 |
| 2017-08 | 0 | $0 | 20,442 | $214,001 | 0 | $0 |
| 2017-07 | 0 | $0 | 62,328 | $659,547 | 0 | $0 |
| 2017-06 | 0 | $0 | 10,903 | $133,570 | 0 | $0 |
| 2017-05 | 0 | $0 | 735 | $74,444 | 0 | $0 |
| 2017-04 | 0 | $0 | 165,918 | $1,833,288 | 0 | $0 |
| 2017-02 | 0 | $0 | 0 | $0 | 1,235 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-02 | Webster Stephen W | Sale | 7,826 | .19 | 1,486 |
| 2022-08-02 | Broom Colin Md | Sale | 5,339 | .19 | 1,014 |
| 2022-08-02 | Corrigan Mark | Sale | 10,297 | .19 | 1,956 |
| 2022-08-02 | Burgess Daniel D | Sale | 11,341 | .19 | 2,154 |
| 2022-08-01 | Bourdow Carrie L. | Sale | 8,540 | .17 | 1,485 |
| 2022-08-01 | Rowland Charles A Jr | Sale | 8,496 | .17 | 1,486 |
| 2021-12-28 | Schroeder Theodore R (Chief Executive Officer) | Buy | 100,000 | .57 | 57,299 |
| 2021-12-27 | Naftzger J. Christopher (General Counsel and Corp Sec) | Buy | 7,000 | .59 | 4,130 |
| 2021-09-14 | Schroeder Theodore R (Chief Executive Officer) | Buy | 50,000 | 1.13 | 56,499 |
| 2021-08-02 | Bourdow Carrie L. | Sale | 777 | 1.20 | 932 |
| 2021-08-02 | Webster Stephen W | Sale | 777 | 1.20 | 932 |
| 2021-08-02 | Rowland Charles A Jr | Sale | 777 | 1.20 | 932 |
| 2021-08-02 | Broom Colin Md | Sale | 531 | 1.20 | 637 |
| 2021-08-02 | Burgess Daniel D | Sale | 1,125 | 1.20 | 1,350 |
| 2020-08-20 | Broom Colin Md (Director) | Sale | 11,064 | .65 | 7,169 |
| 2020-08-19 | Lavino Francesco Maria (Chief Commercial Officer) | Option Ex | 11,250 | .00 | 0 |
| 2020-08-19 | Gelone Steven P. (President and COO) | Option Ex | 27,250 | .00 | 0 |
| 2020-08-19 | Sender Gary (Chief Financial Officer) | Option Ex | 11,250 | .00 | 0 |
| 2020-08-19 | Crotty Robert (Gen Counsel & Corp Secretary) | Option Ex | 11,250 | .00 | 0 |
| 2020-08-19 | Broom Colin Md (Director) | Option Ex | 33,750 | .00 | 0 |
| 2019-08-30 | Broom Colin Md (Director) | Buy | 10,177 | 2.03 | 20,669 |
| 2019-08-27 | Schroeder Theodore R (Chief Executive Officer) | Buy | 50,000 | 1.79 | 89,500 |
| 2019-08-22 | Lavino Francesco Maria (Chief Commercial Officer) | Buy | 4,800 | 2.04 | 9,782 |
| 2019-08-19 | Lavino Francesco Maria (Chief Commercial Officer) | Option Ex | 11,250 | .00 | 0 |
| 2019-08-19 | Gelone Steven P. (President and COO) | Option Ex | 27,250 | .00 | 0 |
| 2019-08-19 | Sender Gary (Chief Financial Officer) | Option Ex | 11,250 | .00 | 0 |
| 2019-08-19 | Crotty Robert (Gen Counsel & Corp Secretary) | Option Ex | 11,250 | .00 | 0 |
| 2019-08-19 | Broom Colin Md (Director) | Option Ex | 33,750 | .00 | 0 |
| 2018-12-24 | Rowland Charles A Jr (Director) | Buy | 53,000 | 1.31 | 69,430 |
| 2018-07-31 | Talbot George Harrison (Director) | Buy | 14,500 | 2.75 | 39,875 |
| 2018-07-31 | Burgess Daniel D (Director) | Buy | 36,000 | 2.75 | 99,000 |
| 2018-06-23 | Gelone Steven P. (Chief Scientific Officer) | Buy | 10,000 | 3.82 | 38,200 |
| 2018-06-22 | Schranz Jennifer (Chief Medical Officer) | Buy | 5,500 | 3.73 | 20,515 |
| 2018-06-22 | Broom Colin Md (CEO & Director) | Buy | 5,000 | 3.72 | 18,600 |
| 2018-05-23 | Lavino Francesco Maria (Chief Commercial Officer) | Buy | 2,160 | 4.60 | 9,936 |
| 2018-05-23 | Sender Gary (Chief Financial Officer) | Buy | 2,000 | 4.57 | 9,140 |
| 2018-05-23 | Crotty Robert (General Counsel & Secretary) | Buy | 10,000 | 4.48 | 44,800 |
| 2018-05-23 | Webster Stephen W (Director) | Buy | 8,000 | 4.59 | 36,720 |
| 2018-05-23 | Broom Colin Md (CEO & Director) | Buy | 10,000 | 4.60 | 46,000 |
| 2017-11-29 | Lavino Francesco Maria (Chief Commercial Officer) | Buy | 1,569 | 6.29 | 9,869 |
| 2017-09-27 | Talbot George Harrison (Director) | Option Ex | 1,350 | .00 | 0 |
| 2017-09-22 | Sender Gary (Chief Financial Officer) | Buy | 2,000 | 8.21 | 16,420 |
| 2017-09-22 | Broom Colin Md (Chief Executive Officer) | Buy | 2,588 | 8.35 | 21,609 |
| 2017-09-18 | Vivo Capital Viii, Llc | Buy | 52,631 | 9.46 | 497,889 |
| 2017-09-14 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 3,429 | 8.52 | 29,225 |
| 2017-09-13 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 22,721 | 8.54 | 193,946 |
| 2017-09-12 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 10,458 | 8.63 | 90,231 |
| 2017-08-31 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 639 | 9.50 | 6,070 |
| 2017-08-08 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 2,013 | 10.50 | 21,136 |
| 2017-08-07 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 17,790 | 10.50 | 186,795 |
| 2017-07-28 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 6,585 | 10.51 | 69,195 |
| 2017-07-24 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 160 | 10.50 | 1,680 |
| 2017-07-20 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 23,445 | 10.50 | 246,172 |
| 2017-07-19 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 20,786 | 10.50 | 218,253 |
| 2017-07-03 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 11,352 | 10.95 | 124,247 |
| 2017-06-30 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 1,775 | 10.94 | 19,420 |
| 2017-06-29 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 1,603 | 10.72 | 17,188 |
| 2017-06-28 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 4,789 | 11.10 | 53,157 |
| 2017-06-27 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 2,166 | 10.83 | 23,457 |
| 2017-06-19 | Talbot George Harrison (Director) | Sale | 46 | 91.00 | 4,186 |
| 2017-06-16 | Talbot George Harrison (Director) | Sale | 24 | 93.50 | 2,244 |
| 2017-06-15 | Talbot George Harrison (Director) | Sale | 100 | 94.10 | 9,410 |
| 2017-06-01 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 400 | 11.27 | 4,508 |
| 2017-05-30 | Talbot George Harrison (Director) | Sale | 210 | 101.25 | 21,262 |
| 2017-05-25 | Talbot George Harrison (Director) | Sale | 295 | 100.75 | 29,721 |
| 2017-05-23 | Talbot George Harrison (Director) | Sale | 30 | 99.70 | 2,991 |
| 2017-05-16 | Talbot George Harrison (Director) | Sale | 150 | 102.63 | 15,395 |
| 2017-05-15 | Talbot George Harrison (Director) | Sale | 50 | 101.50 | 5,075 |
| 2017-04-28 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 15,130 | 11.03 | 166,808 |
| 2017-04-27 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 100 | 11.00 | 1,100 |
| 2017-04-26 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 709 | 11.00 | 7,799 |
| 2017-04-21 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 2,622 | 11.04 | 28,936 |
| 2017-04-20 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 325 | 11.00 | 3,575 |
| 2017-04-19 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 11,785 | 11.07 | 130,436 |
| 2017-04-18 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 11,822 | 11.16 | 131,886 |
| 2017-04-13 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 10,984 | 11.13 | 122,229 |
| 2017-04-12 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 13,250 | 11.22 | 148,651 |
| 2017-04-11 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 8,597 | 11.40 | 98,031 |
| 2017-04-10 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 37,876 | 10.73 | 406,447 |
| 2017-04-07 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 21,501 | 11.00 | 236,511 |
| 2017-04-06 | Hbm Healthcare Investments (cayman) Ltd. | Sale | 31,217 | 11.24 | 350,879 |
| 2017-02-16 | Talbot George Harrison (Director) | Option Ex | 1,235 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of NBRV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nabriva Therapeutics Plc (symbol NBRV, CIK number 1641640) see the Securities and Exchange Commission (SEC) website.